Optimizing a Rare Disease Asset for Commercialization

Thought Leaders:

Angie Wheeler, CEO, Cello Health Insight, Chicago
Jim McDermott, Vice President, Cello Health BioConsulting
John Howley, Managing Director, Cello Health Communications, US

August 15, 2016

In this episode, our panel of experts will talk about the state of the rare disease space, and how to succeed in this growing arena.

There is also a related white paper on this topic, which you can download using the link at the bottom of this listing.

Length: 16:56       Size: 7.75MB

Post a Comment

You must be logged in to post a Comment.

FEEDBACK